Platinum TAQ DNA Polymerase kit, 5000 reactions per kit
ID: PlatinumTaqType: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFOFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION (ASA)PROGRAM SUPPORT CENTER ACQ MGMT SVCROCKVILLE, MD, 20857, USA

NAICS

Medical Equipment and Supplies ManufacturingT (3391)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/9db940f601774ad08d359f92b2c759d0/view
Timeline
    Description

    The Department of Health and Human Services (HHS) intends to award a Firm-Fixed Price Contract to Life Technologies Inc. for the provision of the Platinum TAQ DNA Polymerase kit, which supports 5000 reactions per kit. This procurement is specifically aimed at supporting the BioWatch Laboratory Operations, highlighting the critical role of this reagent in public health and safety initiatives. Interested vendors are invited to express their capabilities by emailing Leslie Lucas at leslie.lucas@hhs.gov by 10:00 am EST on September 18, 2024, although the government reserves the right to proceed without competition under the authority of specific federal regulations.

    Point(s) of Contact
    Leslie Lucas
    (443) 947-6076
    (410) 642-3566
    leslie.lucas@psc.hhs.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Platinum TAQ DNA Polymerase kit, 5000 reactions per kit
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Notice of Intent to Sole Source - Biosearch Technologies
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to negotiate a sole source contract with Biosearch Technologies, Inc. for the production of proprietary PCR kits essential for the Laboratory Response Network (LRN). The procurement aims to ensure a consistent supply of reagents necessary for detecting biothreat agents and emerging infectious diseases, which are critical for national preparedness and response capabilities. These kits, which must comply with FDA quality standards, are vital for high-security laboratories and are designed to identify various bioterrorism agents. Interested parties may submit capability statements or proposals to Matthew Nelson at mnelson2@cdc.gov by November 7, 2024, at 3:30 PM EST for consideration.
    Sources Sought-BioFire Reagents and Test Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is conducting a Sources Sought announcement to identify potential qualified small businesses capable of supplying BioFire Defense reagents and test kits. The NIH's Department of Laboratory Medicine requires these reagents for their BioFire FilmArray analyzers, which are essential for the rapid detection of infectious agents from clinical samples, thereby facilitating timely treatment. Interested vendors must submit their company information, including a capability statement, by 12:00 PM EST on November 7, 2024, to Sheri Eiri at sheri.eiri@nih.gov, as the government will not reimburse any costs associated with this request.
    Title: Global Life Sciences Sepax Cell Separation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed-price contract for the procurement of Global Life Sciences Sepax Cell Separation Kits and Ficoll Paque Premium reagents. The NIH's Department of Transfusion Medicine requires these items to support the manufacturing of cell-based therapies for patients with advanced metastatic cancer, utilizing the Sepax C-Pro Cell Processing Instruments. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source award to Cytiva-Global Life Sciences Solutions USA LLC, with capability statements due by November 3, 2024, at 12:00 PM EST. Interested parties can direct inquiries to Sheri Eiri at sheri.eiri@nih.gov.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    BPA Master - Reagents for Luminex 3D
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to establish a Blanket Purchase Agreement on a sole source basis with One Lambda, Inc. for the procurement of laboratory reagents essential for the Luminex 3D Instrument System. This procurement is justified under the statutory authority permitting Other than Full and Open Competition, as outlined in FAR 6.302-1, indicating that only One Lambda can meet the agency's specific requirements. The reagents are crucial for immunology testing and transplantation compatibility, supporting the operations of the Immunology Lab Department at Walter Reed National Military Medical Center. Interested parties capable of providing the requested reagents must submit their capabilities and pricing by 10:00 am EST on November 8, 2024, via email to the designated contacts, Ealed Nuru and Erica S. Oh.
    Procurement of storage and stability services to maintain BARDA’s supply of Live Attenuated Influenza Virus Master and Working Seed Lots
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS), specifically the Biomedical Advanced Research and Development Authority (BARDA), is seeking to procure storage and stability services for maintaining its supply of Live Attenuated Influenza Virus Master and Working Seed Lots. The procurement aims to ensure that these seed lots remain within specification for use in clinical trials or commercial drug production, which is critical for pandemic preparedness. The contract will be awarded on a sole source basis to MedImmune, LLC, which has been performing these services under a previous indefinite-delivery, indefinite-quantity contract since 2016. Interested parties may submit capability statements or quotations for consideration, and inquiries can be directed to Deitra Williams at deitra.williams@hhs.gov or Corneilus Stephens at corneilus.stephens@hhs.gov.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking sources for the procurement of Illumina Reagents and Consumables. This opportunity aims to identify potential suppliers capable of providing essential reagents and consumables used in genomic sequencing and related research applications. These products are critical for advancing biomedical research and supporting various health initiatives. Interested vendors should reach out to Ethan Mueller at ethan.mueller@nih.gov for further details regarding this sources sought notice.
    Preventative Maintenance Agreement for Sciex Triple Quad 6500 Systems
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to establish a Preventative Maintenance Agreement for two Sciex Triple Quad 6500 Systems utilized by the Department of Laboratory Medicine at the NIH Clinical Center. This contract aims to ensure optimal performance through annual preventative maintenance and timely repairs, which are critical for maintaining uninterrupted laboratory services for both clinical and research purposes. The selected vendor, Ab Sciex LLC, is the sole manufacturer of the equipment and will provide comprehensive coverage under the Sciex Assurance and Software Plus Plans, ensuring access to OEM parts and software support for a period from December 22, 2024, to December 21, 2027. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 8, 2024, at 6:30 AM EST, as this is not a request for proposal and the total contract value will not exceed $250,000.
    Reagent Generation for Bioanalytical Method Development on Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources for a potential contract focused on reagent generation for bioanalytical method development related to biologics. The primary objective is to obtain information on the availability and capability of companies to generate and deliver reagents, including anti-drug antibodies, that support the quantification of novel biologic drugs in various biological matrices. This initiative is crucial for advancing drug development processes and improving success rates in preclinical stages, with the Therapeutic Development Branch (TDB) at NIH playing a pivotal role in moving therapeutic candidates through the drug development pipeline. Interested parties must submit their capability statements by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov, referencing sources sought notice number 75N95025R00007.